Alveolar epithelial NF-κB/RelA guards the lung against bacterial infection

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Immunology

Background:

• Acute respiratory distress syndrome (ARDS) is a severe lung injury with high mortality and no effective treatments.
• Infections frequently cause ARDS, activating the transcription factor NF-κB, a potential therapeutic target.

Purpose of the Study:

• To investigate the role of NF-κB, specifically RelA, in alveolar epithelial cells during bacterial lung infection and ARDS.
• To determine if RelA in lung epithelial cells is essential for preventing infection-induced lung injury.

Main Methods:

• Utilized lung epithelial cell-specific knockout mice (RelA deletion in AT2 cells).
• Infected mice with Pseudomonas aeruginosa to model bacterial pneumonia.
• Assessed mortality, lung injury, epithelial barrier permeability, protein leakage, bacterial load, and immune cell infiltration.

Main Results:

• Mice lacking RelA in alveolar epithelial type 2 (AT2) cells exhibited significantly higher mortality after infection compared to wild-type controls.
• RelA-deficient mice showed increased lung injury, barrier dysfunction, and alveolar protein leakage.
• Bacterial and immune cell loads were similar between groups, indicating an intrinsic epithelial cell mechanism.

Conclusions:

• RelA within AT2 cells is essential for maintaining cell survival and lung integrity during bacterial infection.
• NF-κB (RelA) plays a previously unrecognized protective role in preventing ARDS.
• These findings provide a mechanistic basis for developing NF-κB-targeted therapies for ARDS.